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1. INTRODUCTION
jj Annual review is an established feature of CF care:
js It allows a global and systematic assessment of the different aspects of CF. 
js It facilitates collaboration and communication with the multidisciplinary team members.
js It helps patient education on CF management.  
jj It can be conducted as 
js a ‘specific annual review visit’, i.e. half-day to perform the investigations and a dedicated 
visit to discuss/summarize the results.
js a ‘continuous assessment’, i.e. evaluation of the various items/points during the regular 
patient visits throughout the year.
jj An annual medical report is created for the patient’s file and for the doctors implicated in 
the care of the patient.
jj A list of points and items to be considered during the annual review or at least on an annual 
basis are presented in Tables 1 and 2.
 Table 1:  Items and points to consider during the annual review or at least 
annually
General Assessment
Clinical Interview –  Medical and life events since previous annual review
–  Hospitalizations and use of health-care resources (including
specialized consultations conducted since previous annual review)
–  History by systems
• Respiratory
• ENT
• Digestive
• Allergies
• Endocrinology/metabolism: diabetes, bone disease
• Renal and urinary (e.g. nephrolithiasis, incontinence)
• Gynecology, contraception, maternity, paternity
• Psychological problems
• Social and insurance issues, work, education
–  Other according to clinical indications
(continued)
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Clinical examination –  Vital signs including SatO2, blood pressure, weight, height (BMI)
–  Cardiopulmonary examination
–  Basic ENT examination (throat inspection, good nasal breathing on
both sides).
–  Abdominal examination
–  Other according to clinical indications
Treatment review –  Treatment modifications since previous annual review
–  Adherence to treatment
–  Number and type of antibiotic courses (oral, iv) since previous
annual review
–  Review of vaccination status (flu vaccination confirmation,
whooping cough, anti-pneumococcal vaccination)
–  Renewal of annual prescription
–  Prescription for travelling (on demand)
Venous access –  PAC function, intervals of care discussed with the CF nurse
Respiratory system 
therapy and 
Physiotherapy 
–  Annual review by an experienced respiratory physiotherapist (either the
CF center physiotherapist or the patient’s personal physiotherapist) –
information on CF physiotherapists can be found in
www.cf-physio.ch
–  Inhalation therapy review and adherence to treatment
–  Review of the sequence of inhalation therapies
–  Nasal/sinus therapy review
–  Review of physiotherapy techniques: competence
–  Review of material maintenance: function, cleanliness
Dietary assessment –  Annual assessment by the CF center dietician
–  Weight curve and BMI
–  Current diet - energy, protein and calcium intake
–  Adequacy of pancreatic enzyme replacement therapy
–  Bioelectric impedance analysis (BIA) for selected patients
–  Blood prealbumin levels for selected patients
Clinical pharmacology For selected cases according to clinical indications
Psychologist For selected cases according to clinical indications
Social worker Suggested to all patients - information on social workers dedicated to 
adult CF patients can be found in the site of CFCH  
www.cfch.ch/fr/prestations/soutien-et-conseil/assistantes-sociaux
Respiratory functional tests
Pulmonary function 
tests (PFTs)
–  For all patients: Spirometry, plethysmography
–  Optional: Diffusing capacity
–  Reversibility testing if newly observed obstructive syndrome and/
or in selected cases (at any time point – not necessarily during the
annual assessment)
–  Lung clearance index, if available, for selected cases (e.g. adults
with normal spirometry to detect early changes)
–  Arterial blood gases for selected cases
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Exercise testing  
(6-min walk test, 
3-min step test,
ergospirometry)
For selected cases according to clinical indications
Oxymetry/ 
capnooxymetry
For selected cases according to clinical indications
Laboratory analysis
Complete blood count For all patients
Prothrombin time, INR For all patients
Biochemistry –  Inflammatory markers: CRP, total IgG
–  Renal function and electrolytes: Creat, Urea, Na, K, Cl-, HCO3-,
Ca, Mg
–  Liver function tests : AST, ALT, γGT, ALP, bilirubin
–  Pancreatic tests in selected cases: lipase, amylase
–  Fat soluble vitamins: A, D, E
–  Prealbumin in selected cases
–  Total cholesterol, LDL, HDL, triglycerides for patients >40 years-old
or CF-related diabetes or family history of hyperlipidemia
ABPA screening –  Total IgE for all patients
–  In case of IgE elevation and ABPA suspicion assess A. fumigatus
specific IgE, skin testing and precipitins
Glycemic control –  For diabetic patients:
– assessment by a diabetologist
–  fasting glucose, random capillary glycemia (including 2h post
prandial glycemia values), HbA1c, assessment for diabetes- 
related complications (retinopathy, nephropathy, neuropathy)
–  For non diabetic patients: Oral glucose tolerance test (OGTT)
–  For selected cases: The indication for continuous glucose monito-
ring system (CGMS) should be discussed with a diabetologist
Urine Analysis –  Urinary calcium excretion (24h urine collection or ratio of calcium/
creatinine in a fasting spot, morning urine sample)
–  For diabetic patients: glycosuria, albuminuria
Faecal analysis –  Faecal pancreatic elastase in selected cases
Imaging studies
Chest X-radiography 
Chest CT-scan 
–  Annual chest X-radiography is NOT recommended for all patients
routinely
–  A paired inspiratory/expiratory chest CT-scan, with minimal radiation
protocol and without contrast medium is proposed at initial patient
evaluation (e.g. at transition from paediatric care, or at diagnosis for
patients diagnosed in adulthood)
(continued)
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–  If a chest CT-scan with a minimal radiation protocol is available, it
is recommended every 2-3 years. If not, plain chest radiography is
recommended every 1-2 years depending on the clinical status.
Abdominal ultrasound Annually. Elastography may be added in selected cases.
Bone densitometry Dual energy X-ray absorptiometry scanning every 2-5 years
Microbiological analysis
Review of microbiology 
results
–  Colonizing and intermittently present microorganisms
–  Last positive culture for P. aeruginosa, MRSA, mycobacteria, rare
microorganisms
Sputum microbiology –  Standard microbiology (including B. cepacia complex) and
mycology
–  Culture for non-tuberculous mycobacteria at least annually
 Table 2: Specialist consultations to consider 
ENT specialist –  In selected cases
–  Audiometry for patients receiving IV aminoglycosides
≥1x/year and for selected patients treated with azithromycin
Diabetologist –  At least annually for diabetic patients
Ophtalmologist –  Annually for diabetic patients
–  Before initiation and during treatment with ivacaftor
(evaluation for cataract)
Bone disease specialist –  Annually for patients with low trauma fracture, osteoporosis
treatment or difficult to treat vitD deficiency despite good
dosing and adherence
Gastro-enterologist – Colonoscopy screening: after 40 years of age (see also
Chapter ‘‘Aging in Cystic Fibrosis’’).
Follow-up at   the discretion of the gastro-enterologist.
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